Industry News: Pain Management Global Summit

04 Oct 2011

Join the industry professionals in attendance at Senate House - City of London, UK on the 25th - 26th Oct 2011 for a chance to discuss the latest trends and developments in Pain Management.

The Global Pain Management market is estimated to generate more than $40 billion and is forecast to reach $60 billion by 2015. According to industry analysts more than 1.5 billion people globally suffer from chronic pain.

Network with senior level executives from the top 20 pharmaceutical and biotechnology industries.
Our summit will focus on Examining the current challenges and accelerating innovation in drugs for pain management.

Hear key addresses from leading academics at Cambridge university concerning the contribution of science to understanding of pain mechanisms. Scientific presentations will provide in-depth coverage on topics including translational biomarkers in the development of novel analgesic drugs, with sessions dedicated to Laser induced analgesia.

The conference will focus on main areas of:

1) Exploring research and innovation for new drugs in development
2) The use of biologic therapies for pain management
3) Challenges in animal modeling
4) Gene therapy for pain management
5) Human experimental trials in pain research
6) Translational pain
7) The commercial & business aspects of pain management

Speakers Include:

•Dr Chas Bountra, Chief Scientist, University of Oxford
•Dr Jan Smith, Director, Theravance (USA)
•Dr Ali Ardati, Director, Sr Research Fellow, Sanofi-Aventis
•Prof Peter McNaughton, Chief Scientist, University of Cambridge
•Dr James Carroll, CEO, THOR Photomedicine Ltd
•Dr Jonathan Stewart, Honorary Consultant, St Mary’s Hospital

For further information and the opportunity to register online please visit the company article page